Effects of long-chain acyl carnitine on membrane fluidity of human erythrocytes

Biochim Biophys Acta. 1989 Apr 28;980(3):315-8. doi: 10.1016/0005-2736(89)90318-0.

Abstract

Amphiphilic compounds such as long-chain acyl carnitines accumulate in ischemic myocardium and potentially contribute to the myocardial damage. To characterize alterations in membrane molecular dynamics produced by palmitoylcarnitine, human erythrocytes were spin-labeled with 5-doxylstearic acid, and membrane fluidity was quantified by measuring the changes in the order parameter derived from ESR spectra. Palmitoylcarnitine induced triphasic alterations in membrane fluidity of human erythrocytes. The membrane fluidity increased for 5 min, then decreased in a concentration-dependent manner. At higher concentrations (100 and 150 microM) of palmitoylcarnitine, membrane fluidity increased again after 30 and 20 min of the incubation, respectively. Addition of 2.8 mM CaCl2 resulted in a significant decrease in membrane fluidity and enhanced the alterations in membrane fluidity caused by palmitoylcarnitine. The results suggest that alterations in molecular dynamics are one mechanism through which long-chain acyl carnitine could play an important role in ischemic injury.

MeSH terms

  • Acetylcarnitine / pharmacology*
  • Adult
  • Calcium Chloride / pharmacology
  • Carnitine / analogs & derivatives*
  • Electron Spin Resonance Spectroscopy
  • Erythrocyte Membrane / drug effects*
  • Humans
  • Membrane Fluidity / drug effects*
  • Palmitoylcarnitine / pharmacology

Substances

  • Palmitoylcarnitine
  • Acetylcarnitine
  • Calcium Chloride
  • Carnitine